Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 3/20 | 0.33 |
| ▸ | CTSB | P07858 | 3/20 | 0.33 |
| ▸ | CTSH | P09668 | 2/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentamine SCHEMBL13479599 | 1.00 | CTSK (0.40) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Levopropylhexedrine SCHEMBL161851 | 0.98 | CTSK (0.42) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Levopropylhexedrine SCHEMBL20780004 | 0.98 | CTSK (0.42) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Propylhexedrine SCHEMBL28537 | 0.98 | CTSK (0.42) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Cyclopentamine SCHEMBL317336 | 0.98 | CTSK (0.39) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Propylhexedrine SCHEMBL4900116 | 0.95 | CTSK (0.41) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| Propylhexedrine SCHEMBL28890426 | 0.95 | CTSK (0.41) | CTSKMEN1KMT2ASIGMAR1CTSL | |
| SCHEMBL27308544 | 0.95 | — | — | |
| SCHEMBL22627190 | 0.83 | CTSK (0.32) | CTSK | |
| SCHEMBL23241391 | 0.81 | OPRK1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3530 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094930-A | Recovery of purified material from crude mixture | — | 2026-05-26 | — | — | CN | claimed |
| CN-119233997-A | Tetrahedral antibodies | 生物分子控股有限责任公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4463485-A2 | TETRAHEDRAL ANTIBODIES | Biomolecular Holdings LLC (US) | 2024-11-20 | — | — | EP | claimed |
| CN-118384290-A | Hybrid immunoglobulins containing non-peptide linkages | 生物分子控股有限责任公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117772270-A | Double-function catalyst for packaging Ni@H-MCM-22 molecular sieve and preparation method thereof | 中国石油化工股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117690620-A | Pouring type high-temperature-resistant heat-conducting resin-based neutron shielding composite material and preparation method thereof | 中国船舶集团有限公司第七一九研究所 | 2024-03-12 | — | — | CN | claimed |
| US-20230364224-A1 | Pharmaceutical Composition For Allergen Specific Immunotherapy | HOPITAUX UNIVERSITAIRES DE GENEVE (CH) | 2023-11-16 | — | — | US | claimed |
| EP-4213873-A1 | COMPOSITE SOLDER BALLS METALLISED ON THE SURFACE AND CALIBRATED FOR THE ASSEMBLY OF ELECTRONIC BOARDS | Hopitaux Universitaires de Genève (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2023137387-A2 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-20 | — | — | WO | claimed |
| WO-2023137373-A1 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-20 | — | — | WO | claimed |
| WO-1997004764-A1 | TOPICAL PHENYLEPHRINE PREPARATION | ARMSTRONG KENNETH T (CA) | 1997-02-13 | — | — | WO | claimed |
| CN-1031876-C | Explosive composition | ICI AUSTRALIA OPERATIONS (AU) | 1996-05-29 | — | — | CN | claimed |
| CN-1111226-A | Explosive composition | ICI AUSTRALIA OPERATIONS (AU) | 1995-11-08 | — | — | CN | claimed |
| CN-1110676-A | Preparation of citraconic anhydride | RHONE POULENC CHIMIE (FR) | 1995-10-25 | — | — | CN | claimed |
| CN-1105026-A | Process for production of fluoroalkanecarboxamide derivatives | SUMITOMO CHEMICAL CO (JP) | 1995-07-12 | — | — | CN | claimed |
| CN-1095069-A | Novel process for the preparation and/or purification of clavulanic acid or pharmaceutically acceptable salts or esters thereof | SMITHKLINE BEECHAM PLC (GB) | 1994-11-16 | — | — | CN | claimed |
| CN-1063680-A | The synthetic method of cyclopentamine | UNIV NANKAI (CN) | 1992-08-19 | — | — | CN | claimed |
| CN-1035490-A | EXPLOSIVE COMPOSITION | ICI AUSTRALIA OPERATIONS (AU) | 1989-09-13 | — | — | CN | claimed |
| US-4203912-A | ANTITUMOR | JOHNSON, MATTHEY & CO., LIMITED (GB) | 1980-05-20 | — | — | US | claimed |
| US-3968245-A | Sympathomimetic topical and percutaneous administration with halogenated promoters | ALZA CORPORATION (US) | 1976-07-06 | — | — | US | claimed |